Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

OptimizeRx (OPRX) Current Assets (2016 - 2026)

OptimizeRx's Current Assets history spans 16 years, with the latest figure at $64.7 million for Q4 2025.

  • On a quarterly basis, Current Assets rose 19.91% to $64.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $64.7 million, a 19.91% increase, with the full-year FY2025 number at $64.7 million, up 19.91% from a year prior.
  • Current Assets hit $64.7 million in Q4 2025 for OptimizeRx, up from $56.3 million in the prior quarter.
  • Over the last five years, Current Assets for OPRX hit a ceiling of $115.1 million in Q4 2021 and a floor of $46.0 million in Q2 2024.
  • Historically, Current Assets has averaged $79.7 million across 5 years, with a median of $86.2 million in 2023.
  • Biggest five-year swings in Current Assets: surged 297.94% in 2021 and later plummeted 49.57% in 2024.
  • Tracing OPRX's Current Assets over 5 years: stood at $115.1 million in 2021, then fell by 14.37% to $98.6 million in 2022, then plummeted by 44.88% to $54.3 million in 2023, then dropped by 0.66% to $54.0 million in 2024, then increased by 19.91% to $64.7 million in 2025.
  • Business Quant data shows Current Assets for OPRX at $64.7 million in Q4 2025, $56.3 million in Q3 2025, and $54.1 million in Q2 2025.